Humana 2004 Annual Report Download - page 115

Download and view the complete annual report

Please find page 115 of the 2004 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

Humana Inc.
SCHEDULE I—PARENT COMPANY FINANCIAL INFORMATION
CONDENSED BALANCE SHEETS
December 31,
2004 2003
(in thousands, except share
amounts)
ASSETS
Current assets:
Cash and cash equivalents ............................................ $ 242,868 $ 321,676
Investment securities ................................................ 196,420 77,717
Receivable from operating subsidiaries ................................. 115,813 78,834
Securities lending collateral .......................................... 7,991 —
Other current assets ................................................. 67,696 79,531
Total current assets ............................................. 630,788 557,758
Property and equipment, net .............................................. 292,523 281,168
Investments in subsidiaries ............................................... 2,530,458 2,384,709
Notes receivable from operating subsidiaries ................................. 17,000 17,000
Other ................................................................ 75,087 66,180
Total assets ................................................... $3,545,856 $3,306,815
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Payable to operating subsidiaries ...................................... $ 400,960 $ 379,583
Current portion of notes payable to operating subsidiaries ................... 27,600 27,600
Book overdraft ..................................................... 53,526 130,948
Other current liabilities .............................................. 211,595 164,716
Securities lending payable ............................................ 7,991 —
Total current liabilities .......................................... 701,672 702,847
Long-term debt ........................................................ 636,696 642,638
Notes payable to operating subsidiaries ..................................... 18,000 18,000
Other ................................................................ 99,364 107,381
Total liabilities ................................................ 1,455,732 1,470,866
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $1 par; 10,000,000 shares authorized; none issued ........... —
Common stock, $0.16
2
3
par; 300,000,000 shares authorized; 176,044,649 shares
issued in 2004, and 173,909,127 shares issued in 2003 ................... 29,340 28,984
Treasury stock, at cost, 15,778,088 shares in 2004, and 12,018,281 shares in
2003 ........................................................... (201,000) (133,976)
Other stockholders’ equity ........................................... 2,261,784 1,940,941
Total stockholders’ equity ........................................ 2,090,124 1,835,949
Total liabilities and stockholders’ equity ............................ $3,545,856 $3,306,815
See accompanying notes to the parent company financial statements.
105